240 WAY-102: an <i>in vivo</i> lentiviral dual-armored CLDN18.2 CAR T engineered for long-term durability & cytotoxicity in the tumor microenvironmentCassandra Kontur, David V. Phizicky, Liang He et al.|Regular and Young Investigator Award Abstracts|2025Cited by 0